Cencora, Inc.
CORHealthcareNASDAQMedical Distribution
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Cencora, Inc. focuses on Medical Distribution services and products. Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company carries a $51.53B market cap, placing it firmly in the large-cap category.
Market Cap
$51.53B
Beta
0.65
P/E (TTM)
20.28
P/E (Fwd)
13.37
EPS (TTM)
$13.06
EPS (Fwd)
$19.81
ROE
107.1%
ROA
3.5%
Cash
$2.18B
Total Debt
$15.09B
Free CF
-$318.2M
52W Change
-8.4%
Annual Financials
Cash vs Debt
The company holds $2.18B in cash, though total debt stands at $15.09B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$318.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at 107.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $238.59B (2022) to $321.33B (2025), reflecting a 35% increase over the period.
With a beta below 0.7, Cencora, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Cencora, Inc. and its sector.